Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2011 Financial Results - MarketWatch (press release) PDF Print
MarketWatch (press release)
Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, ...
Keryx Biopharmaceuticals Inc (KERX) Posts Quarterly Earnings Results, Misses

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.